GRP
TRIB

Global Retirement Partners’s Trinity Biotech TRIB Stock Holding History

Global Retirement Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-800
Closed -$1.7K – 3647
2024
Q2 		$1.7K Hold
800
– – ﹤0.01% 3027
2024
Q1 		$1.63K Buy
+800
New +$1.87K ﹤0.01% 2825

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Global Retirement Partners's TRIB Position: Q3 2024 in Review

Global Retirement Partners sold out of Trinity Biotech (TRIB) in Q3 2024, closing a stake of 800 shares — an estimated $1.7K sold.

Global Retirement Partners first reported a position in TRIB in Q1 2024 and held it in 2 quarters. The position peaked at $1.7K in Q2 2024. 19 funds tracked by Wall St. Rank hold TRIB as of Q3 2024.

  • Global Retirement Partners reported no remaining Trinity Biotech position as of Q3 2024 after selling out during the quarter.
  • Global Retirement Partners sold 800 Trinity Biotech shares in Q3 2024, an estimated $1.7K.
  • Global Retirement Partners first reported a position in Trinity Biotech in Q1 2024 and held it in 2 quarters.
  • Global Retirement Partners's Trinity Biotech position peaked at $1.7K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2024.

Based on Global Retirement Partners's 13F filing for Q3 2024, filed 16 Oct 2024.